After nearly two years of criticism from activists and White House, Moderna unveils a new plan for global health

Moderna, the target of nearly two years of criticism for its policies around global access to its Covid-19 vaccine, announced on Monday a new plan to address global health.

The mRNA biotech said it would launch a four-part program. First, it would put vaccines into clinical testing for 15 pathogens that could either cause future pandemics, such as Nipah virus or Zika, or that primarily affect the developing world, such as tuberculosis and malaria.